By Scientia Professor Matthew Colm Kiernan

Journal articles

Gray E; Menadue C; Piper A; Wong K; Yee B; Kiernan M, 2024, 'Hypercapnia is not excluded by normoxia in neuromuscular disease patients: implications for oximetry', Erj Open Research, 10, http://dx.doi.org/10.1183/23120541.00927-2023

Dharmadasa T; Pavey N; Tu S; Menon P; Huynh W; Mahoney CJ; Timmins HC; Higashihara M; van den Bos M; Shibuya K; Kuwabara S; Grosskreutz J; Kiernan MC; Vucic S, 2024, 'Novel approaches to assessing upper motor neuron dysfunction in motor neuron disease/amyotrophic lateral sclerosis: IFCN handbook chapter', Clinical Neurophysiology, 163, pp. 68 - 89, http://dx.doi.org/10.1016/j.clinph.2024.04.010

Higashihara M; Pavey N; Menon P; van den Bos M; Shibuya K; Kuwabara S; Kiernan MC; Koinuma M; Vucic S, 2024, 'Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study', European Journal of Neurology, 31, http://dx.doi.org/10.1111/ene.16281

Besomi M; Devecchi V; Falla D; McGill K; Kiernan MC; Merletti R; van Dieën JH; Tucker K; Clancy EA; Søgaard K; Hug F; Carson RG; Perreault E; Gandevia S; Besier T; Rothwell JC; Enoka RM; Holobar A; Disselhorst-Klug C; Wrigley T; Lowery M; Farina D; Hodges PW, 2024, 'Consensus for experimental design in electromyography (CEDE) project: Checklist for reporting and critically appraising studies using EMG (CEDE-Check)', Journal of Electromyography and Kinesiology, 76, http://dx.doi.org/10.1016/j.jelekin.2024.102874

Li T; Timmins HC; Mahfouz FM; Mizrahi D; Horvath L; Harrison ML; Grimison PS; Friedlander M; Marx GM; Boyle FM; Wyld D; Henderson R; King T; Baron-Hay SE; Kiernan MC; Rutherford C; Goldstein D; Park SB, 2024, 'Identifying optimized assessment of nerve damage during chemotherapy.', Journal of Clinical Oncology, 42, pp. 12016 - 12016, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.12016

Li T; Trinh T; Bosco A; Kiernan MC; Goldstein D; Park SB, 2024, 'Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes', Supportive Care in Cancer, 32, http://dx.doi.org/10.1007/s00520-024-08484-5

Eisen A; Pioro EP; Goutman SA; Kiernan MC, 2024, 'Nanoplastics and Neurodegeneration in ALS', Brain Sciences, 14, http://dx.doi.org/10.3390/brainsci14050471

Silsby M; Yiannikas C; Fois AF; Kennerson ML; Kiernan MC; Fung VSC; Vucic S, 2024, 'Upper and lower limb tremor in Charcot–Marie–Tooth neuropathy type 1A and the implications for standing balance', Journal of Neurology, 271, pp. 1776 - 1786, http://dx.doi.org/10.1007/s00415-023-12124-z

Carroll AS; Park SB; Lin CSY; Taylor MS; Kwok F; Simon NG; Reilly MM; Kiernan MC; Vucic S, 2024, 'Axonal excitability as an early biomarker of nerve involvement in hereditary transthyretin amyloidosis', Clinical Neurophysiology, 159, pp. 81 - 95, http://dx.doi.org/10.1016/j.clinph.2024.01.006

Eisen A; Nedergaard M; Gray E; Kiernan MC, 2024, 'The glymphatic system and Amyotrophic lateral sclerosis', Progress in Neurobiology, 234, http://dx.doi.org/10.1016/j.pneurobio.2024.102571

Silsby M; Yiannikas C; Fois AF; Kiernan MC; Fung VSC; Vucic S, 2024, 'Upper and lower limb tremor in inflammatory neuropathies', Clinical Neurophysiology, 158, pp. 69 - 78, http://dx.doi.org/10.1016/j.clinph.2023.12.005

Devenney EM; Tse NY; O’Callaghan C; Kumfor F; Ahmed RM; Caga J; Hazelton JL; Carrick J; Halliday GM; Piguet O; Kiernan MC; Hodges JR, 2024, 'An attentional and working memory theory of hallucination vulnerability in frontotemporal dementia', Brain Communications, 6, http://dx.doi.org/10.1093/braincomms/fcae123

Carroll AS; Razvi Y; O’Donnell L; Veleva E; Heslegrave A; Zetterberg H; Vucic S; Kiernan MC; Rossor AM; Gillmore JD; Reilly MM, 2024, 'Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice', Amyloid, 31, pp. 95 - 104, http://dx.doi.org/10.1080/13506129.2024.2313218

Henden L; Fearnley LG; Southwood D; Smith A; Rowe DB; Kiernan MC; Pamphlett R; Bahlo M; Blair IP; Williams KL, 2024, 'Short tandem repeat expansions in LRP12 are absent in cohorts of familial and sporadic amyotrophic lateral sclerosis patients of European ancestry', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25, pp. 644 - 647, http://dx.doi.org/10.1080/21678421.2024.2348636

Wippich A; Howatson G; Allen-Baker G; Farrell D; Kiernan M; Scott-Bell A, 2024, 'Eye Movement Desensitization Reprocessing as a Treatment for PTSD in Conflict-Affected Areas', PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY, 16, pp. S561 - S567, http://dx.doi.org/10.1037/tra0001430

Dharmadasa T; Pavey N; Tu S; Menon P; Huynh W; Mahoney CJ; Timmins HC; Higashihara M; Bos MVD; Shibuya K; Kuwabara S; Grosskreutz J; Kiernan MC; Vucic S, 2024, 'Novel approaches to assessing upper motor neuron dysfunction in motor neuron disease/amyotrophic lateral sclerosis: IFCN handbook chapter', CLINICAL NEUROPHYSIOLOGY, 163, pp. 68 - 89, http://dx.doi.org/10.1016/j.clinph.2024.04.0101388-2457

Tan RH; McCann H; Shepherd CE; Pinkerton M; Mazumder S; Devenney EM; Adler GL; Rowe DB; Kril J; Halliday GM; Kiernan MC, 2023, 'Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis', Acta Neuropathologica Communications, 11, http://dx.doi.org/10.1186/s40478-023-01670-2

Kiernan MC; Halliday GM; Rowe DB; Tan RH, 2023, 'The importance of patient-centred drug development for amyotrophic lateral sclerosis', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12944

Pavey N; Hannaford A; Higashihara M; van den Bos M; Kiernan MC; Menon P; Vucic S, 2023, 'Utility of split hand index with different motor unit number estimation techniques in ALS', Clinical Neurophysiology, 156, pp. 175 - 182, http://dx.doi.org/10.1016/j.clinph.2023.09.018

Kiernan MC; Farrar MA, 2023, 'Emerging role for sphingolipids in the genetics of amyotrophic lateral sclerosis', Journal of Neurology Neurosurgery and Psychiatry, 95, pp. 101 - 102, http://dx.doi.org/10.1136/jnnp-2023-332719

Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA, 2023, 'Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia', Clinical Neurophysiology, 154, pp. 157 - 168, http://dx.doi.org/10.1016/j.clinph.2023.08.002

Silsby M; Yiannikas C; Fois AF; Ng K; Kiernan MC; Fung VSC; Vucic S, 2023, 'Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy', Journal of the Peripheral Nervous System, 28, pp. 415 - 424, http://dx.doi.org/10.1111/jns.12574

Farrar MA; Kiernan MC; Kariyawasam DS, 2023, 'Presymptomatic spinal muscular atrophy: a cautionary approach to the proposed new terminology', Brain, 146, pp. E65 - E66, http://dx.doi.org/10.1093/brain/awad061

Pinkerton M; Lourenco G; Pacheco MT; Halliday GM; Kiernan MC; Tan RH, 2023, 'Survival in sporadic ALS is associated with lower p62 burden in the spinal cord', Journal of Neuropathology and Experimental Neurology, 82, pp. 769 - 773, http://dx.doi.org/10.1093/jnen/nlad051

Timmins HC; Vucic S; Kiernan MC, 2023, 'Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis', Current Opinion in Neurology, 36, pp. 353 - 359, http://dx.doi.org/10.1097/WCO.0000000000001162

Kiernan MC; Park SB, 2023, 'Hyperexcitability, neurodegeneration, and disease progression in amyotrophic lateral sclerosis', Muscle and Nerve, 68, pp. 103 - 105, http://dx.doi.org/10.1002/mus.27843

Yang Y; Rowe D; McCann H; Shepherd CE; Kril JJ; Kiernan MC; Halliday GM; Tan RH, 2023, 'Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12919

Willemse SW; Harley P; Van Eijk RPA; Demaegd KC; Zelina P; Pasterkamp RJ; Van Damme P; Ingre C; Van Rheenen W; Veldink JH; Kiernan MC; Al-Chalabi A; Van Den Berg LH; Fratta P; Van Es MA, 2023, 'UNC13A in amyotrophic lateral sclerosis: From genetic association to therapeutic target', Journal of Neurology Neurosurgery and Psychiatry, 94, pp. 649 - 656, http://dx.doi.org/10.1136/jnnp-2022-330504

Kiernan M, 2023, 'Case 14-2023: A Man with Redness of the Right Eye', NEW ENGLAND JOURNAL OF MEDICINE, 389, pp. 383 - 383, http://dx.doi.org/10.1056/NEJMc2307114

Kiernan MF; Gillmore JD; Gupta T, 2023, 'Slowly progressive descending facial nerve paralysis indicates hereditary gelsolin amyloidosis', LANCET, 401, pp. 2072 - 2072, http://dx.doi.org/10.1016/s0140-6736(23)01063-2

Vucic S; Stanley Chen KH; Kiernan MC; Hallett M; Benninger DH; Di Lazzaro V; Rossini PM; Benussi A; Berardelli A; Currà A; Krieg SM; Lefaucheur JP; Long Lo Y; Macdonell RA; Massimini M; Rosanova M; Picht T; Stinear CM; Paulus W; Ugawa Y; Ziemann U; Chen R, 2023, 'Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee', Clinical Neurophysiology, 150, pp. 131 - 175, http://dx.doi.org/10.1016/j.clinph.2023.03.010

Menon P; Pavey N; Aberra AS; van den Bos MAJ; Wang R; Kiernan MC; Peterchev AV; Vucic S, 2023, 'Dependence of cortical neuronal strength-duration properties on TMS pulse shape', Clinical Neurophysiology, 150, pp. 106 - 118, http://dx.doi.org/10.1016/j.clinph.2023.03.012

Vucic S; Menon P; Huynh W; Mahoney C; Ho KS; Hartford A; Rynders A; Evan J; Evan J; Ligozio S; Glanzman R; Hotchkin MT; Kiernan MC, 2023, 'Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension', Eclinicalmedicine, 60, http://dx.doi.org/10.1016/j.eclinm.2023.102036

Shimatani Y; Lin CSY; Matamala JM; Kiernan MC, 2023, 'Strength-duration properties and excitability of motor and sensory axons across different target thresholds', Journal of Neurophysiology, 129, pp. 1434 - 1446, http://dx.doi.org/10.1152/jn.00456.2022

Kiernan MC; Burke D; Tan RH, 2023, 'The lower motor neuron homunculus: function matters', Brain, 146, pp. E34 - E35, http://dx.doi.org/10.1093/brain/awad021

Henden L; Fearnley LG; Grima N; McCann EP; Dobson-Stone C; Fitzpatrick L; Friend K; Hobson L; Moi Fat SC; Rowe DB; D Silva S; Kwok JB; Halliday GM; Kiernan MC; Mazumder S; Timmins HC; Zoing M; Pamphlett R; Adams L; Bahlo M; Blair IP; Williams KL, 2023, 'Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia', Science Advances, 9, http://dx.doi.org/10.1126/sciadv.ade2044

Pavey N; Menon P; van den Bos MAJ; Kiernan MC; Vucic S, 2023, 'Cortical inhibition and facilitation are mediated by distinct physiological processes', Neuroscience Letters, 803, http://dx.doi.org/10.1016/j.neulet.2023.137191

Krishnan D; Kiernan MC, 2023, 'Neurotoxic risks from over-the-counter vitamin supplements', Medical Journal of Australia, 218, pp. 304 - 306, http://dx.doi.org/10.5694/mja2.51851

Silsby M; Fois AF; Yiannikas C; Ng K; Kiernan MC; Fung VSC; Vucic S, 2023, 'Chronic inflammatory demyelinating polyradiculoneuropathy-associated tremor: Phenotype and pathogenesis', European Journal of Neurology, 30, pp. 1059 - 1068, http://dx.doi.org/10.1111/ene.15693

Mazumder S; Mccann H; D'silva S; Furlong S; Shepherd CE; Kril JJ; Halliday GM; Rowe DB; Kiernan MC; Tan RH, 2023, 'Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis', Brain, 146, pp. E17 - E19, http://dx.doi.org/10.1093/brain/awac467

Martinez-Valdes E; Enoka RM; Holobar A; McGill K; Farina D; Besomi M; Hug F; Falla D; Carson RG; Clancy EA; Disselhorst-Klug C; van Dieën JH; Tucker K; Gandevia S; Lowery M; Søgaard K; Besier T; Merletti R; Kiernan MC; Rothwell JC; Perreault E; Hodges PW, 2023, 'Consensus for experimental design in electromyography (CEDE) project: Single motor unit matrix', Journal of Electromyography and Kinesiology, 68, pp. 102726, http://dx.doi.org/10.1016/j.jelekin.2022.102726

Timmins HC; Mizrahi D; Li T; Kiernan MC; Goldstein D; Park SB, 2023, 'Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review', Journal of Cancer Survivorship, 17, pp. 222 - 236, http://dx.doi.org/10.1007/s11764-021-00988-x

Li T; Timmins HC; Trinh T; Mizrahi D; Harrison M; Horvath LG; Grimison P; Friedlander M; Kiernan MC; King MT; Rutherford C; Goldstein D; Park SB, 2023, 'Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes', Jnccn Journal of the National Comprehensive Cancer Network, 21, pp. 125 - 132, http://dx.doi.org/10.6004/jnccn.2022.7074

Kutlubaev MA; Caga J; Xu Y; Areprintseva DK; Pervushina EV; Kiernan MC, 2023, 'Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24, pp. 14 - 23, http://dx.doi.org/10.1080/21678421.2022.2053721

Hannaford A; Byth K; Pavey N; Henderson RD; Mathers S; Needham M; Schultz D; Menon P; Kiernan MC; Vucic S, 2023, 'Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosis', Muscle and Nerve, 67, pp. 17 - 24, http://dx.doi.org/10.1002/mus.27736

Moreno-Roco J; Del Valle L; Jiménez D; Acosta I; Castillo JL; Dharmadasa T; Kiernan MC; Matamala JM, 2023, 'Diagnostic utility of transcranial magnetic stimulation for neurodegenerative disease: a critical review', Dementia E Neuropsychologia, 17, http://dx.doi.org/10.1590/1980-5764-DN-2023-0048

Tse NY; Bocchetta M; Todd EG; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Kiernan MC; Piguet O; Rohrer JD; Ahmed RM, 2023, 'Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum', Neuroimage Clinical, 37, http://dx.doi.org/10.1016/j.nicl.2022.103281

Phan K; He Y; Bhatia S; Pickford R; Mcdonald G; Mazumder S; Timmins HC; Hodges JR; Piguet O; Dzamko N; Halliday GM; Kiernan MC; Kim WS, 2023, 'Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis', Brain Communications, 5, http://dx.doi.org/10.1093/braincomms/fcac340

Vucic S; Kiernan MC, 2023, 'Nanocrystalline gold (CNM-Au8): a novel bioenergetic treatment for ALS', Expert Opinion on Investigational Drugs, 32, pp. 783 - 785, http://dx.doi.org/10.1080/13543784.2023.2263368

Silsby M; Fois A; Ng K; Yiannikas C; Kiernan M; Fung V; Vucic S, 2023, 'N°51 – Phenotype and pathogenesis of upper limb tremor in CIDP', Clinical Neurophysiology, 150, pp. e88 - e88, http://dx.doi.org/10.1016/j.clinph.2023.03.060

Back to profile page